SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-07-036933
Filing Date
2007-05-08
Accepted
2007-05-08 14:47:46
Documents
6
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a07-10633_110q.htm 10-Q 653705
2 EX-3.4 a07-10633_1ex3d4.htm EX-3.4 9944
3 EX-3.5 a07-10633_1ex3d5.htm EX-3.5 124757
4 EX-31.1 a07-10633_1ex31d1.htm EX-31.1 11041
5 EX-31.2 a07-10633_1ex31d2.htm EX-31.2 11728
6 EX-32 a07-10633_1ex32.htm EX-32 10122
  Complete submission text file 0001104659-07-036933.txt   822781
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 07827716
SIC: 2834 Pharmaceutical Preparations